B-cell Lymphoma
Showing NaN - NaN of 6
B-cell Malignancy, Non-Hodgkin Lymphoma, B-cell Lymphoma Trial in Worldwide (CTX110)
Recruiting
- B-cell Malignancy
- +3 more
- CTX110
-
Los Angeles, California
- +27 more
May 6, 2022
B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, ALL Trial in Boston (Venetoclax, Dexamethasone, Inotuzumab Ozogamicin)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- Venetoclax
- +2 more
-
Boston, Massachusetts
- +1 more
Oct 19, 2021
Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma Trial in United States
Completed
- Relapsed or Refractory Lymphoproliferative Malignancies
- +4 more
- Pralatrexate Injection
- +3 more
-
Los Angeles, California
- +14 more
Dec 27, 2019
B-cell Lymphoma, Indolent B-cell Lymphoma Trial in Boston (rituximab)
Completed
- B-cell Lymphoma
- Indolent B-cell Lymphoma
-
Boston, Massachusetts
- +1 more
May 9, 2017
